Auxilium Signs Sobi As Pfizer Replacement In Europe
This article was originally published in The Pink Sheet Daily
Executive Summary
The maker of Xiaflex/Xiapex has found a new commercialization partner in the EU after its first partnership fell apart due to disappointing sales of the drug in those territories.